U.S. drugmaker Biogen to pay $900 million to settle federal whistleblower case
Sept. 27 (UPI) -- U.S. drugmaker Biogen will pay $900 million to settle a federal whistleblower lawsuit that alleged the company overbilled the nation's health insurance programs a…